Last reviewed · How we verify
Asymptomatic left ventricular systolic dysfunction
Approved treatments
- Vasotec · Azurity
Vasotec works by blocking the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor. - Vasotec · Merck & Co.
ACE inhibitor prodrug that is converted to enalaprilat, blocking angiotensin-converting enzyme to lower blood pressure. - Vasotec · Biovail Labs Intl
Vasotec works by blocking the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Asymptomatic left ventricular systolic dysfunction patent landscape — cliff calendar, originator estates, attackable patents
- Asymptomatic left ventricular systolic dysfunction treatment landscape brief
- Asymptomatic left ventricular systolic dysfunction treatment updates RSS
Frequently asked questions about Asymptomatic left ventricular systolic dysfunction
What drugs treat Asymptomatic left ventricular systolic dysfunction?
Tracked treatments include Vasotec.
What is the treatment for Asymptomatic left ventricular systolic dysfunction?
Standard treatment for Asymptomatic left ventricular systolic dysfunction includes Vasotec. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Asymptomatic left ventricular systolic dysfunction patent cliff · Asymptomatic left ventricular systolic dysfunction CI report
- Treatment: Vasotec · Azurity
- Treatment: Vasotec · Merck & Co.
- Treatment: Vasotec · Biovail Labs Intl
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing